Both Semaglutide and the drug represent innovative approaches to treating type 2 diabetes, and increasingly, obesity. Semaglutide is a dual agonist that works on multiple hormones involved in blood sugar control: the incretin hormone and another incretin. This medication, often viewed as a produc